WHO WE ARE
Aztron Medtech is dedicated to advancing orthopedic soft tissue repair through innovative medical devices. Our multidisciplinary team—comprising orthopedic surgeons, medical engineers, and seasoned marketing professionals—works together to develop cutting-edge solutions that enhance surgical precision and patient outcomes.
Meet Aztron MedTech
Ben Huang
MS, College of Medicine, NTU UCSD Visiting Scholar
I-Lin Tsai
Co-Founder & COO
MS, College of Medicine, NTU
Steven Chen
CTO
20 years of Product Design experience
Chen-Chie Wang, MD, PhD
Foot, Ankle Orthopedic Surgeon
Director of Tissue Engineering Stem Cell Center, Taipei Tzu Chi Hospital
Chung-Li Wang, MD.PhD
KOL, Advisor
Foot, Ankle Orthopedic Surgeon
Professor, NTUH
Director of NTUH Yunlin Branch
Our Advisors
Partner with renowned surgeons and leading experts to develop cutting-edge solutions for orthopedic soft tissue repair.
Our Milestones
2024
2023
2022
2021
2025
Rebranded as Aztron Medtech
National Innovation Award, Taiwan
First in Human
FDA Listed
Seed Round Completed
Medtech Innovator APAC
MassChallenge 2022 B2MC Cohort
SelectUSA Medtech World Championship
UC Berkeley SPH Program
FITI National Winner
SNQ Award
In the United States
We have begun to establish ourselves in the US market, collaborating with the UC Berkeley School of Public Health.
In 2022, Astron Medtech (now rebranded as Aztron Medtech) won the top prize of the 2022 SelectUSA Investment Summit in the MedTech categories against 16 other finalists (was Astron Medtech at the moment . In 2024, Aztron Medtech received FDA clearance and completed the First In Human.
In Taiwan
We have a strong collaboration with Tzu Chi Hospital where the technology has been implemented in 150+ clinical cases. We received the SNQ award in 2021 and National Innovation Award in 2024.
